Richard Poulton - Nov 15, 2022 Form 4 Insider Report for ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (MDRX)

Role
CEO, Director
Signature
Holly Teague by power of attorney for Richard Poulton
Stock symbol
MDRX
Transactions as of
Nov 15, 2022
Transactions value $
-$362,018
Form type
4
Date filed
11/16/2022, 04:34 PM
Previous filing
Aug 16, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDRX Common Stock Sale -$181K -10K -1.37% $18.14 723K Nov 15, 2022 Direct F1, F2
transaction MDRX Common Stock Gift $0 -23.5K -3.25% $0.00 699K Nov 15, 2022 Direct
transaction MDRX Common Stock Sale -$181K -10K -1.43% $18.06 689K Nov 16, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares reported in the Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2021.
F2 These transactions were executed in multiple trades at prices ranging from $17.90 to $18.36. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected.
F3 These transactions were executed in multiple trades at prices ranging from $17.62 to $18.17. The prices reported reflect the weighted average sale price on the transaction date. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected.